7-氯-3-甲酰基吲哚
|
C342127-5g
|
≥97% |
1008-07-7 |
5g
|
¥ 2594.9
|
现货 |
阿拉丁 |
7-氯-3-甲酰基吲哚
|
C342127-1g
|
≥97% |
1008-07-7 |
1g
|
¥ 679.9
|
现货 |
阿拉丁 |
柳黄酸
|
C342095-10mg
|
|
63944-54-7 |
10mg
|
¥ 2092.9
|
期货,请咨询 |
阿拉丁 |
CGS-12066A马来酸盐
|
C342012-25mg
|
|
1350965-83-1 |
25mg
|
¥ 399.9
|
期货,请咨询 |
阿拉丁 |
(+)-氯丁烯醇(钠盐)
|
C342011-5mg
|
|
62561-03-9 |
5mg
|
¥ 2736.9
|
期货,请咨询 |
阿拉丁 |
(+)-氯丁烯醇(钠盐)
|
C342011-1mg
|
|
62561-03-9 |
1mg
|
¥ 684.9
|
期货,请咨询 |
阿拉丁 |
头孢克洛
|
C342003-250mg
|
Moligand™, ≥97%(HPLC) |
53994-73-3 |
250mg
|
¥ 41.9
|
现货 |
阿拉丁 |
5-(氯磺酰基)-1-甲基-1H-吡唑
|
C341972-1g
|
|
1020721-61-2 |
1g
|
¥ 1255.9
|
期货,请咨询 |
阿拉丁 |
5-(氯磺酰基)-1-甲基-1H-吡唑
|
C341972-250mg
|
|
1020721-61-2 |
250mg
|
¥ 880.9
|
期货,请咨询 |
阿拉丁 |
3-甲基六氢吡咯并[1,2-a]吡嗪-1,4-二酮
|
C341921-1g
|
≥99% |
36238-64-9 |
1g
|
¥ 6624.9
|
期货,请咨询 |
阿拉丁 |
3-甲基六氢吡咯并[1,2-a]吡嗪-1,4-二酮
|
C341921-250mg
|
≥99% |
36238-64-9 |
250mg
|
¥ 2205.9
|
期货,请咨询 |
阿拉丁 |
Cadralazine
|
C341918-100mg
|
≥98% |
64241-34-5 |
100mg
|
¥ 487.9
|
现货 |
阿拉丁 |
Cadralazine
|
C341918-10mg
|
≥98% |
64241-34-5 |
10mg
|
¥ 273.9
|
现货 |
阿拉丁 |
2-氯-2-脱氧-D-葡萄糖
|
C341891-100mg
|
|
14685-79-1 |
100mg
|
¥ 13945.9
|
期货,请咨询 |
阿拉丁 |
2-氯-2-脱氧-D-葡萄糖
|
C341891-50mg
|
|
14685-79-1 |
50mg
|
¥ 8110.9
|
期货,请咨询 |
阿拉丁 |
2-氯-2-脱氧-D-葡萄糖
|
C341891-10mg
|
|
14685-79-1 |
10mg
|
¥ 2589.9
|
期货,请咨询 |
阿拉丁 |
Conduritol B
|
C341889-25mg
|
|
25348-64-5 |
25mg
|
¥ 1312.9
|
期货,请咨询 |
阿拉丁 |
2'-氯-2'-脱氧胞苷
|
C341839-5g
|
|
10212-19-8 |
5g
|
¥ 86035.9
|
期货,请咨询 |
阿拉丁 |
2'-氯-2'-脱氧胞苷
|
C341839-1g
|
|
10212-19-8 |
1g
|
¥ 21788.9
|
期货,请咨询 |
阿拉丁 |
1-[4-(氯乙酰基)苯基]吡咯烷-2-酮
|
C341813-1g
|
|
923200-17-3 |
1g
|
¥ 2783.9
|
期货,请咨询 |
阿拉丁 |
1-[4-(氯乙酰基)苯基]吡咯烷-2-酮
|
C341813-250mg
|
|
923200-17-3 |
250mg
|
¥ 1375.9
|
期货,请咨询 |
阿拉丁 |
1-(环丙基甲基)-5-氧吡咯烷-3-羧酸
|
C341784-1g
|
≥95% |
845546-16-9 |
1g
|
¥ 1891.9
|
期货,请咨询 |
阿拉丁 |
1-(环丙基甲基)-5-氧吡咯烷-3-羧酸
|
C341784-250mg
|
≥95% |
845546-16-9 |
250mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |
5′-氯5′-脱氧腺苷
|
C341772-250mg
|
≥97% |
892-48-8 |
250mg
|
¥ 39.9
|
期货,请咨询 |
阿拉丁 |